Skip to the page content
Your donations
Passes our checks

Global Colon Cancer Association

EIN 46-0657002 · Washington, DC

Public records show a registered, tax-exempt organization in good standing.

LegitimacyPassesRegistration and standingFinancial healthFair69 out of 100GovernanceWeak46 out of 100Impact evidenceDescribes programsHow well its results are evidenced

What it says it does

THE CORPORATION WILL EFFECTIVELY ADDRESS THE ISSUES AND PROVIDE INFORMATION SURROUNDING COLORECTAL CANCER TO CLINICIANS, PATIENTS AND CAREGIVERS ACROSS THE GLOBE.

Income
$888,276
Spending
$989,457
Spent on programs
98%
Reserves
4.2 months of spending
Largest source of income
donations and private grants, 100%
Employees
0
Volunteers
250
Highest pay
$148,856, president

Source: Form 990 for the year ending December 31, 2024, filed with the Internal Revenue Service. Rating method 2026.2. How we rate

Financial health

Fair: 69 out of 100. Higher than 28% of charities in its peer group (diseases, $250k to $1m).

  • Reserves

    20 of 35

    Spendable reserves would cover 4.2 months of spending.

  • Debt

    20 of 20

    It owes 0% of what it owns.

  • Living within its means

    4 of 15

    Spending exceeded income by 11% of income.

  • Income trend

    10 of 15

    Income fell 10% on the year before.

  • Spending floor

    15 of 15

    98% of spending went to programs and raising each dollar of donations cost 0 cents.

Source: Form 990 for the year ending December 31, 2024, filed with the Internal Revenue Service. Rating method 2026.2. How we rate

Governance

Weak: 46 out of 100. Higher than 12% of charities in its peer group (diseases, $250k to $1m).

  • Independent board

    25 of 25

    5 of 5 voting board members are independent.

  • Conflict of interest policy

    0 of 15

    Reports no written conflict of interest policy.

  • Whistleblower policy

    0 of 8

    Reports no written whistleblower policy.

  • Record keeping policy

    0 of 7

    Reports no written policy on keeping and destroying records.

  • Board minutes

    5 of 5

    Keeps minutes of board meetings.

  • Board sees the tax return

    0 of 10

    Did not give the board a copy of this return before filing it.

  • Pay set independently

    0 of 5

    Reports no independent review process for its chief executive's pay.

  • Independent check of accounts

    6 of 15

    Its accounts were not audited or reviewed by an independent accountant.

  • No reported misuse

    10 of 10

    Reports no diversion of assets, excess benefits or loans to insiders.

Source: Form 990 for the year ending December 31, 2024, filed with the Internal Revenue Service. Rating method 2026.2. How we rate

Impact evidence

Describes programs. Its tax return describes what it does but we have found no measurable results in it.

Programs described in its return (3)
  1. $287,701 spent. GROWING AND SUPPORTING THE INTERNATIONAL COLON CANCER COMMUNITY - THE GCCA NOW REPRESENTS MORE THAN 100 NOT FOR PROFIT ORGANIZATIONS FROM 50 COUNTRIES. OUR MEMBERSHIP OF PATIENT GROUPS HAS INCREASED THE ORGANIZATION'S FOOTPRINT IN THE INTERNATIONAL PATIENT GROUP ARENA. WE USE SOCIAL MEDIA AND EMAIL TO COMMUNICATE WITH BOTH THE CRC COMMUNITY AT LARGE AND TO OUR MEMBER GROUPS. HAVING EVERY CRC GROUP IN THE WORLD MAKES THE ORGANIZATION MUCH STRONGER IN THE POLICY ARENA AND WHEN ADVOCATING ON BEHALF OF THE COLON CANCER COMMUNITY. THROUGH THIS WORK, WE HAVE GAINED MORE CREDIBILITY WITH POTENTIAL FUNDERS AS WELL AS POLICYMAKERS AROUND THE GLOBE. THIS HAS RESULTED IN AN INCREASE IN FUNDING AS WELL AS ADVOCACY WORK.
  2. $331,456 spent. ADVOCATING FOR PATIENT-CENTERED POLICY - THE GCCA IS A LEADER IN THE INTERNATIONAL POLICY ARENA, REPRESENTING MORE THAN 6,000,000 COLORECTAL CANCER PATIENTS AROUND THE WORLD. THE GCCA INVESTS SUBSTANTIAL TIME IN REPRESENTING THE PATIENT PERSPECTIVE TO REGULATORS, POLICYMAKERS AND OTHER RELEVANT STAKEHOLDERS, INCLUDING THE FDA, EMA, WHO AND OTHER GOVERNING BODIES WHEREVER POSSIBLE. THE GCCA'S POLICY TRAVEL EXPENSES ARE PAID BY OTHER COALITIONS SO THE ORGANIZATION DOES NOT INCUR A GREAT DEAL OF EXPENSES IN COMPARISON TO THE AMOUNT OF WORK PERFORMED.
  3. $349,540 spent. EDUCATION - ADDRESSING THE NEEDS OF THE COLON CANCER COMMUNITY AND THE GENERAL PUBLIC IS THE KEY TO TACKLING THE PROBLEMS ASSOCIATED WITH COLON CANCER. WITH THE DISEASE BEING THE MOST PREVENTABLE MAJOR CANCER THROUGH SCREENING, EDUCATING PEOPLE ABOUT SCREENINGS IS A MAJOR MISSION OF THE GCCA AND ALL OF ITS MEMBERS. IN 2024, WE HELD OUR 5TH ANNUAL COLORECTAL CANCER CONGRESS, WHICH PROVIDED CRITICAL DISEASE EDUCATION. OUR KNOW YOUR BIOMARKER PROGRAM EXPANDED IN CONTENT AND REACH, AS WELL AS OUR CLINICAL TRIAL AWARENESS PROGRAM TO INCREASE PARTICIPATION AND UNDERSTANDING OF CLINICAL TRIALS. FURTHER, THE GCCA ATTENDS MAJOR ONCOLOGY AND GASTROENTEROLOGY CONFERENCES WHERE WE FREQUENTLY ARE ALSO INVITED TO SPEAK, PRESENT, OR OTHERWISE EDUCATE THE PATIENT ADVOCATE COMMUNITY. LASTLY, THE GCCA EDUCATES THROUGH SOCIAL MEDIA AND OTHER PROGRAMS WE CURRENTLY HAVE WHERE WE PROVIDE FORUMS FOR PATIENT EDUCATION AND INFORMATION EXCHANGE AMONG PATIENTS. EDUCATION - ADDRESSING THE NEEDS OF THE COLON CANCER COMMUNITY AND THE GENERAL PUBLIC IS THE KEY TO TACKLING THE PROBLEMS ASSOCIATED WITH COLON CANCER. WITH THE DISEASE BEING THE MOST PREVENTABLE MAJOR CANCER THROUGH SCREENING, EDUCATING PEOPLE ABOUT SCREENINGS IS A MAJOR MISSION OF THE GCCA AND ALL OF ITS MEMBERS. IN 2024, WE HELD OUR 5TH ANNUAL COLORECTAL CANCER CONGRESS, WHICH PROVIDED CRITICAL DISEASE EDUCATION. OUR KNOW YOUR BIOMARKER PROGRAM EXPANDED IN CONTENT AND REACH, AS WELL AS OUR CLINICAL TRIAL AWARENESS PROGRAM TO INCREASE PARTICIPATION AND UNDERSTANDING OF CLINICAL TRIALS. FURTHER, THE GCCA ATTENDS MAJOR ONCOLOGY AND GASTROENTEROLOGY CONFERENCES WHERE WE FREQUENTLY ARE ALSO INVITED TO SPEAK, PRESENT, OR OTHERWISE EDUCATE THE PATIENT ADVOCATE COMMUNITY. LASTLY, THE GCCA EDUCATES THROUGH SOCIAL MEDIA AND OTHER PROGRAMS WE CURRENTLY HAVE WHERE WE PROVIDE FORUMS FOR PATIENT EDUCATION AND INFORMATION EXCHANGE AMONG PATIENTS.

Source: Form 990 for the year ending December 31, 2024, filed with the Internal Revenue Service. Rating method 2026.2. How we rate

Legitimacy checks

  1. Is it registered with the IRS? Passed.

    Listed in the IRS master file of tax-exempt organizations as a 501(c)(3) charitable organization.

    Source: Exempt Organizations Business Master File, Internal Revenue Service, file dated September 7, 2026.

  2. Has the IRS revoked its tax-exempt status? Worth knowing.

    Status was revoked on May 15, 2015 for not filing returns for three years, and reinstated on May 15, 2015.

    Source: Automatic revocation of exemption list, Internal Revenue Service, file dated September 30, 2026.

  3. Are donations tax-deductible? Passed.

    On the IRS list of organizations eligible to receive tax-deductible contributions.

    Source: Publication 78 data: organizations eligible for tax-deductible contributions, Internal Revenue Service, file dated September 10, 2026.

  4. Is it keeping up with its IRS filings? Passed.

    Most recent return on file covers the year ending December 2024.

    Source: Exempt Organizations Business Master File, Internal Revenue Service, file dated September 7, 2026.

  5. How long has it been tax-exempt? Passed.

    Recognized by the IRS since August 2015.

    Source: Exempt Organizations Business Master File, Internal Revenue Service, file dated September 7, 2026.

  6. Is it in good standing with state regulators? Passed.

    Not on California's list of charities barred from soliciting. Other states are not yet checked.

    Source: May Not Operate or Solicit for Charitable Purposes list, California Attorney General, Registry of Charities and Fundraisers, file dated October 7, 2026.

Ratings and checks are our reading of public records, using the published method. They are not a statement about anyone's honesty. If you work for this organization, you can send corrections or results, confirm you want gifts through Veridonate, or ask to be removed from giving.